CARB-X

@CARB_X

A global public-private partnership led by Boston University to fund and support R&D early development of products to combat ....

Vrijeme pridruživanja: srpanj 2016.

Tweetovi

Blokirali ste korisnika/cu @CARB_X

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CARB_X

  1. proslijedio/la je Tweet
    4. velj

    Always important to remind everyone that antibiotics are key components of the healthcare infrastructure

    Poništi
  2. 4. velj

    *NEWS NEWS* -- is awarding Pattern Bioscience up to $6.8M plus $15.1M more if project milestones are met to develop a rapid diagnostic for superbug infections.

    Poništi
  3. proslijedio/la je Tweet
    4. velj
    Poništi
  4. proslijedio/la je Tweet
    2. velj

    “First- and second-line that I had used for years started to fail me,” cystic fibrosis patient Gunnar Esiason says of his experience with .

    Poništi
  5. proslijedio/la je Tweet
    30. sij
    Poništi
  6. proslijedio/la je Tweet
    3. velj
    Poništi
  7. proslijedio/la je Tweet
    2. velj
    Poništi
  8. proslijedio/la je Tweet
    2. velj

    Thoughtful article in ⁦⁩ on both the problem and some of the people working to fix it. ⁦⁩ will spend >$60M in 2020 supporting the innovators ⁦⁩ ⁦⁩ ⁦

    Poništi
  9. proslijedio/la je Tweet
    27. sij
    Poništi
  10. proslijedio/la je Tweet
    27. sij

    “Industry and governments must recognize their shared interests in producing new antibiotics.”

    Poništi
  11. proslijedio/la je Tweet
    27. sij

    In today’s ⁦⁦⁩, ⁦⁩ reflects on latest warnings about the fragility of our antibiotics R&D system - and the urgent action we now need to stabilise it

    Poništi
  12. 27. sij
    Poništi
  13. proslijedio/la je Tweet
    26. sij
    Poništi
  14. 25. sij
    Poništi
  15. proslijedio/la je Tweet
    23. sij

    Deadly Viruses Aren't Pharma's Top Priority. Why Not? Article also describes the innovation trap for antibiotics: the most innovative product sit on the shelf, mostly saved for later

    Poništi
  16. proslijedio/la je Tweet
    21. sij

    A good reason for all large drug companies to be part of the solution

    Poništi
  17. 21. sij

    Why developing new antibiotics is a matter of life and death via

    Poništi
  18. 21. sij

    TODAY Jan 21 at noon CET. Livestream panel on 'The Broken Model of Antimicrobial Resistance'. Moderated by . Lars Rebien Sorensen, Jeremy Farrar, Malin Grape, Thomas Cueni, Jayasree Iyer, Francesca Colombo. Novo Nordisk Foundation. Watch here

    Poništi
  19. proslijedio/la je Tweet
    20. sij

    New reports: see little antibiotic innovation coming. : “Numerous initiatives are underway to reduce resistance, but we also need countries & the pharma industry to step up and contribute with sustainable funding & innovative new medicines.”

    Poništi
  20. 20. sij

    Watch Livestream of panel on urgent need for AMR Innovation moderated by 12:00-13:00 CET, Tues. Jan 21, from Davos. Lars Rebien Sorensen, Jeremy Farrar, Malin Grape, Thomas Cueni, Jayasree Iyer, Francesca Colombo.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·